Will Patient Deaths Derail the CAR-T Train in Autoimmune Disease?

(MedPage Today) -- Two Big Pharma companies have reportedly paused their ongoing trials of chimeric antigen receptor (CAR) T-cell therapies in lupus and other autoimmune inflammatory diseases after some participants suffered severe adverse events...